Skip to main content
Equibles
KLRS logo

KLRS · Kalaris Therapeutics, Inc. · Investor Relations

Track KLRS — free

Use KLRS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KLRS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.02 -0.03 (-1.46%)
Rebalance outlook locked
Market Cap
$48.80M
Shares
23.80M
Volume · Nov 4 28.26K Avg daily vol (3M) 66.51K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-08-11 Kalaris Reports Second Quarter 2026 Financial Results and Provides Business Updates
2026-07-17 Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts
2026-05-12 Kalaris Reports First Quarter 2026 Financial Results and Provides Business Updates
2026-03-17 Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
2025-12-18 Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
2025-12-17 Kalaris Therapeutics Reports Initial Positive Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD
2025-11-12 Kalaris Reports Third Quarter 2025 Financial Results and Provides Business Updates

Past events

Date Event Type
2026-09-15 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-07-17 TH103 Ph 1a Data Presentation at American Society of Retina Specialists Annual Meeting 2026 Presentation
2025-12-17 Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD Call Webcast
2025-12-03 Noble Capital Markets 21st Annual Emerging Growth Equity Conference Conference
2025-11-13 Stifel 2025 Annual Healthcare Conference Conference
2025-09-10 Morgan Stanley 23rd Annual Global Healthcare Conference Conference
2025-06-05 Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference Conference
2025-05-27 Stifel 2025 Virtual Ophthalmology Forum Webcast
2024-11-08 AlloVir and Kalaris Therapeutics Merger Call Webcast

Source: https://investors.kalaristx.com/

Key facts CIK 1754068 CUSIP 482929106 13F (30d) 4 filings 4 filers Visit website Investor relations